ESTRO 2024 - Abstract Book

S2115

Clinical - Sarcoma, skin cancer, melanoma

ESTRO 2024

17. Chuong MD, Freilich JM, Hoffe SE, Fulp W, Weber JM, Almhanna K, et al. Intensity-Modulated Radiation Therapy vs. 3D Conformal Radiation Therapy for Squamous Cell Carcinoma of the Anal Canal. Gastrointest Cancer Res GCR. 2013;6(2):39 – 45. 18. Arbea L, Ramos LI, Martínez-Monge R, Moreno M, Aristu J. Intensity-modulated radiation therapy (IMRT) vs. 3D conformal radiotherapy (3DCRT) in locally advanced rectal cancer (LARC): dosimetric comparison and clinical implications. Radiat Oncol Lond Engl. 2010 Feb 26;5:17. 19. Taggar AS, Graham D, Kurien E, Gräfe JL. Volumetric ‐ modulated arc therapy versus intensity ‐ modulated radiotherapy for large volume retroperitoneal sarcomas: A comparative analysis of dosimetric and treatment delivery parameters. J Appl Clin Med Phys. 2017 Nov 27;19(1):276 – 81.

20. Yan W, Khan MK, Wu X, Simone CB, Fan J, Gressen E, et al. Spatially fractionated radiation therapy: History, present and the future. Clin Transl Radiat Oncol. 2019 Oct 22;20:30 – 8.

21. Asur R, Butterworth KT, Penagaricano JA, Prise KM, Griffin RJ. High dose bystander effects in spatially fractionated radiation therapy. Cancer Lett. 2015 Jan 1;356(1):52 – 7.

22. Iori F, Cappelli A, D’Angelo E, Cozzi S, Ghersi SF, De Felice F, et al. Lattice Radiation Therapy in clinical practice: A systematic review. Clin Transl Radiat Oncol. 2023 Mar;39:100569.

23. Buchwald ZS, Wynne J, Nasti TH, Zhu S, Mourad WF, Yan W, et al. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation. Front Oncol [Internet]. 2018 [cited 2023 Mar 9];8. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306034/

24. Gaudreault M, Chang D, Kron T, et al. Development of an automated treatment planning approach for lattice radiation therapy. Med Phys.2023;1-12. Med Phys. 2023;

25. Ferini G, Parisi S, Lillo S, Viola A, Minutoli F, Critelli P, et al. Impressive Results after “Metabolism - Guided” Lattice Irradiation in Patients Submitted to Palliative Radiation Therapy: Preliminary Results of LATTICE_01 Multicenter Study. Cancers. 2022 Aug 12;14(16):3909. 26. Tubin S, Gupta S, Grusch M, Popper HH, Brcic L, Ashdown ML, et al. Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers. 2020 Dec 26;13(1):50. 27. Allignet B, Waissi W, Geets X, Dufresne A, Brahmi M, Ray-Coquard I, et al. Long-term outcomes after definitive radiotherapy with modern techniques for unresectable soft tissue sarcoma. Radiother Oncol. 2022 Aug 1;173:55 – 61. 28. Liveringhouse CL, Palm RF, Bryant JM, Yang GQ, Mills MN, Figura ND, et al. Neoadjuvant Simultaneous Integrated Boost Radiation Therapy Improves Clinical Outcomes for Retroperitoneal Sarcoma. Int J Radiat Oncol Biol Phys. 2023 Sep 1;117(1):123 – 38. 29. Zhao Q, Chen G, Ye L, Shi S, Du S, Zeng Z, et al. Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC. Radiat Oncol Lond Engl. 2019 May 27;14(1):86.